Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 2/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | EDNRA | P25101 | 2/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6306790 | 1.00 | CA4 (0.43) | CA4LTA4HCES2CES1HSD11B1 | |
| SCHEMBL6306792 | 0.93 | CA4 (0.46) | CA4LTA4HCES2CES1HSD11B1 | |
| SCHEMBL126675 | 0.85 | CA4 (0.59) | CA4LTA4HCES2CES1HSD11B1 | |
| Water SCHEMBL8070408 | 0.83 | CA4 (0.56) | CA4LTA4HCES2CES1HSD11B1 | |
| Bromide SCHEMBL4851524 | 0.83 | CA4 (0.56) | CA4LTA4HCES2CES1HSD11B1 | |
| Fluoride Ion SCHEMBL244398 | 0.83 | CA4 (0.56) | CA4LTA4HCES2CES1HSD11B1 | |
| Hydrochloric Acid SCHEMBL7696226 | 0.83 | CA4 (0.56) | CA4LTA4HCES2CES1HSD11B1 | |
| SCHEMBL1134080 | 0.83 | LMNA (0.30) | TP53MAPT | |
| SCHEMBL7081560 | 0.83 | LMNA (0.30) | TP53MAPT | |
| SCHEMBL9685437 | 0.83 | LMNA (0.30) | TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1591097-B1 | Cationically curing two component materials containing a noble metal catalyst | MINNESOTA MINING MFG GMBH (DE) | 2012-06-20 | — | — | EP | disclosed |
| US-7368524-B2 | Cationically curing two component materials containing a noble metal catalyst | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-05-06 | — | — | US | disclosed |
| US-20060116445-A1 | Cationically curing two component materials containing a noble metal catalyst | 3M DEUTSCHLAND GMBH (DE) | 2006-06-01 | — | — | US | disclosed |
| EP-1591097-A1 | Cationically curing two component materials containing a noble metal catalyst | 3M Espe AG (DE) | 2005-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060116445-A1 | Cationically curing two component materials containing a noble metal catalyst | CAD, ELL, MEP1A | CA4 817/4885LTA4H 1790/4885CES2 379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.